Home -

Account Registration

Already a member?

"*" indicates required fields

Step 1 of 3

Username

Name

Password*

Recommendations: at least 12 characters in length, include a mix of character types (uppercase, lowercase, numbers, special characters %$^&), do not use common words or phrases

Organization

Occupation Category*

Address

This field is hidden when viewing the form

occupational_category_audience_kdm

This field is hidden when viewing the form

occupational_category_audience_kdm

View All

Latest Resources
Saved Resources

Downloadable Resource

Research That Matters – Extended-Release vs. Sublingual Buprenorphine in Actively Using Patients

Downloadable Resource

Research That Matters – Long-Acting Injectable Buprenorphine for Opioid Use Disorder

Editorial

Overdoses Are Up, But Do We Really Need Just More Residential Beds?

On-Demand Education

Transforming The SUD Treatment System: The Shatterproof Treatment Atlas Case Study

Downloadable Resource

Federal Guidelines For Opioid Treatment Programs

Downloadable Resource

Not All Medicare Enrollees Are Continuing Treatment For Opioid Use Disorder

Downloadable Resource

Expansion Of Buprenorphine Treatment Via Telemedicine Encounter & Continuity Of Care Via Telemedicine For Veterans Affairs Patients

Downloadable Resource

Opioid Use Disorder: Treatment With Injectable & Implantable Buprenorphine

Downloadable Resource

Most Health Centers Provide Some Behavioral Health Services To Patients With Substance Use Disorder, Despite Facing Challenges That Limit Comprehensive Treatment

Downloadable Resource

Key Substance Use & Mental Health Indicators In The United States: Results From The 2024 National Survey On Drug Use & Health

All Resources

View All

Research That Matters – Extended-Release vs. Sublingual Buprenorphine in Actively Using Patients

Research That Matters – Long-Acting Injectable Buprenorphine for Opioid Use Disorder

Overdoses Are Up, But Do We Really Need Just More Residential Beds?

Transforming The SUD Treatment System: The Shatterproof Treatment Atlas Case Study

Federal Guidelines For Opioid Treatment Programs

Not All Medicare Enrollees Are Continuing Treatment For Opioid Use Disorder

Expansion Of Buprenorphine Treatment Via Telemedicine Encounter & Continuity Of Care Via Telemedicine For Veterans Affairs Patients

Opioid Use Disorder: Treatment With Injectable & Implantable Buprenorphine

Most Health Centers Provide Some Behavioral Health Services To Patients With Substance Use Disorder, Despite Facing Challenges That Limit Comprehensive Treatment

Key Substance Use & Mental Health Indicators In The United States: Results From The 2024 National Survey On Drug Use & Health

All Resources

Research That Matters – Extended-Release vs. Sublingual Buprenorphine in Actively Using Patients

Research That Matters – Long-Acting Injectable Buprenorphine for Opioid Use Disorder

Overdoses Are Up, But Do We Really Need Just More Residential Beds?

Transforming The SUD Treatment System: The Shatterproof Treatment Atlas Case Study

Federal Guidelines For Opioid Treatment Programs

Not All Medicare Enrollees Are Continuing Treatment For Opioid Use Disorder

Expansion Of Buprenorphine Treatment Via Telemedicine Encounter & Continuity Of Care Via Telemedicine For Veterans Affairs Patients

Opioid Use Disorder: Treatment With Injectable & Implantable Buprenorphine

Most Health Centers Provide Some Behavioral Health Services To Patients With Substance Use Disorder, Despite Facing Challenges That Limit Comprehensive Treatment

Key Substance Use & Mental Health Indicators In The United States: Results From The 2024 National Survey On Drug Use & Health

Accountable = Integrated

Opioid Abuse By The Numbers